XuanwuH Acute Ischemic Stroke Registry

Sponsor
Xuanwu Hospital, Beijing (Other)
Overall Status
Recruiting
CT.gov ID
NCT05208203
Collaborator
(none)
500
1
104
4.8

Study Details

Study Description

Brief Summary

Acute ischemic stroke registry--Xuanwu Hospital(XSR) is an academic, independent, prospective, single center, observational registry study. Consecutive acute ischemic stroke patients assessed in stroke "green channel" of Xuanwu Hospital(China) will be enrolled in our study. Patients receive regular treatment and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of thrombolysis or thrombectomy, procedural complications, intracranial hemorrhage, and functional outcome.The study aim to investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients in "green channel",and verify the effect of the improvement of "green channel" process in the diagnosis and treatment of patients with acute ischemic stroke.

Condition or Disease Intervention/Treatment Phase
  • Other: telephone call d90

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Acute Ischemic Stroke "Green Channel" Registry--Xuanwu Hospital
Actual Study Start Date :
May 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2029

Arms and Interventions

Arm Intervention/Treatment
stroke patients

acute ischemic stroke patients including all treatments.

Other: telephone call d90
telephone call on day 90 to assess the primary outcome (mRs d90)

Outcome Measures

Primary Outcome Measures

  1. modified ranking scale on day (mRs) day 90 [90 days]

    mRs: modified ranking scale; the scale is a commonly used measurement for the degree of disability or dependence in the daily activities of people who have suffered a stroke; scale range 0-6, with 0 - No symptoms. 1 - No significant disability. Able to carry out all usual activities, despite some symptoms. 2 - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3 - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6 - Dead.

Secondary Outcome Measures

  1. Stroke Event [1year]

    The patients were monitored whether they recured ischemic stroke event including transient ischemic attack (TIA) or stroke confirmed by neurologist and diffusion-weighted image MRI.

  2. adverse event [1year]

    The patients were monitored whether they appeared symptomatic intracranial hemorrhage,cerebral hernia or other life-threatening events.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical diagnosis of acute ischemic stroke or transient ischemic attack(TIA)

  • Age >18 years

  • Ethic approval in process

  • Receiving assessment in stroke "green channel" of Xuanwu Hospital

Exclusion Criteria:
  • Non-acute ischemic stroke

Contacts and Locations

Locations

Site City State Country Postal Code
1 Xuanwu Hospital Beijing Beijing China 100053

Sponsors and Collaborators

  • Xuanwu Hospital, Beijing

Investigators

  • Study Chair: qingfeng Ma, MD, Xuanwu Hospital, Beijing

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
qingfengma, MD, Xuanwu Hospital, Beijing
ClinicalTrials.gov Identifier:
NCT05208203
Other Study ID Numbers:
  • qingfeng ma stroke xuanwuH
First Posted:
Jan 26, 2022
Last Update Posted:
Jan 26, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by qingfengma, MD, Xuanwu Hospital, Beijing
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2022